Outcomes	O
of	O
cefazolin	O
versus	O
ceftriaxone	O
therapy	O
in	O
treating	O
lower	B-Multi-tissue_structure
respiratory	I-Multi-tissue_structure
tract	I-Multi-tissue_structure
infections	O
in	O
adults	O
.	O

OBJECTIVE	O
:	O

To	O
determine	O
whether	O
choice	O
of	O
a	O
first	O
-	O
versus	O
third	O
-	O
generation	O
cephalosporin	O
as	O
initial	O
therapy	O
for	O
lower	B-Multi-tissue_structure
respiratory	I-Multi-tissue_structure
tract	I-Multi-tissue_structure
infections	O
in	O
hospitalized	O
adults	O
affects	O
the	O
course	O
and	O
duration	O
of	O
care	O
,	O
both	O
of	O
which	O
may	O
influence	O
antimicrobial	O
treatment	O
cost	O
.	O

DESIGN	O
:	O

Retrospective	O
analysis	O
of	O
discharge	O
abstracts	O
and	O
hospital	O
pharmacy	O
records	O
.	O

SETTING	O
:	O

Forty	O
-	O
eight	O
US	O
acute	O
-	O
care	O
hospitals	O
.	O

PATIENTS	O
:	O

One	O
thousand	O
ninety	O
-	O
two	O
hospitalized	O
adults	O
(	O
aged	O
>	O
17	O
y	O
)	O
with	O
principal	O
diagnoses	O
of	O
lower	B-Multi-tissue_structure
respiratory	I-Multi-tissue_structure
tract	I-Multi-tissue_structure
infections	O
(	O
DRGs	O
79	O
-	O
80	O
,	O
89	O
-	O
90	O
)	O
.	O

INTERVENTIONS	O
:	O

Cefazolin	O
or	O
ceftriaxone	O
,	O
given	O
as	O
sole	O
antimicrobial	O
therapy	O
for	O
at	O
least	O
one	O
day	O
.	O

MAIN	O
OUTCOME	O
MEASURES	O
:	O

(	O
1	O
)	O
The	O
number	O
of	O
patients	O
who	O
received	O
another	O
parenteral	O
antibiotic	O
anytime	O
prior	O
to	O
hospital	O
discharge	O
;	O
(	O
2	O
)	O
the	O
number	O
of	O
days	O
during	O
which	O
patients	O
received	O
any	O
parenteral	O
antibiotic	O
while	O
in	O
the	O
hospital	O
;	O
and	O
(	O
3	O
)	O
the	O
number	O
of	O
days	O
patients	O
remained	O
hospitalized	O
following	O
the	O
start	O
of	O
antibiotic	O
therapy	O
.	O

RESULTS	O
:	O

Patients	O
treated	O
with	O
cefazolin	O
(	O
n	O
=	O
763	O
)	O
were	O
more	O
likely	O
to	O
receive	O
another	O
parenteral	O
antibiotic	O
while	O
in	O
the	O
hospital	O
(	O
30	O
.	O
3	O
vs	O
.	O
20	O
.	O
7	O
percent	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
received	O
more	O
total	O
days	O
of	O
therapy	O
(	O
7	O
.	O
2	O
vs	O
.	O
6	O
.	O
7	O
d	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
those	O
treated	O
with	O
ceftriaxone	O
(	O
n	O
=	O
329	O
)	O
.	O

Although	O
the	O
time	O
to	O
hospital	O
discharge	O
did	O
not	O
differ	O
in	O
the	O
full	O
sample	O
(	O
9	O
.	O
2	O
d	O
for	O
both	O
groups	O
)	O
,	O
it	O
was	O
greater	O
among	O
those	O
receiving	O
cefazolin	O
(	O
8	O
.	O
6	O
vs	O
.	O
8	O
.	O
0	O
d	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
when	O
patients	O
with	O
lengths	O
of	O
stay	O
exceeding	O
24	O
days	O
were	O
excluded	O
from	O
both	O
groups	O
.	O

CONCLUSIONS	O
:	O

In	O
addition	O
to	O
acquisition	O
cost	O
,	O
differences	O
in	O
course	O
and	O
duration	O
of	O
care	O
should	O
be	O
considered	O
when	O
determining	O
the	O
most	O
cost	O
-	O
effective	O
choice	O
for	O
antimicrobial	O
therapy	O
.	O

